Selvita Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Boguslaw Sieczkowski
Algemeen directeur
zł1.1m
Totale compensatie
| Percentage CEO-salaris | 59.8% |
| Dienstverband CEO | no data |
| Eigendom CEO | 5.1% |
| Management gemiddelde ambtstermijn | 2.8yrs |
| Gemiddelde ambtstermijn bestuur | geen gegevens |
Recente managementupdates
Recent updates
Is Selvita (WSE:SLV) Using Too Much Debt?
Sep 26
It's Unlikely That The CEO Of Selvita S.A. (WSE:SLV) Will See A Huge Pay Rise This Year
Jun 14Earnings Report: Selvita S.A. Missed Revenue Estimates By 7.1%
May 26Selvita's (WSE:SLV) Solid Earnings May Rest On Weak Foundations
Apr 03Selvita S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Apr 01Selvita S.A. (WSE:SLV) Analysts Just Cut Their EPS Forecasts Substantially
Oct 07We Think Selvita (WSE:SLV) Can Stay On Top Of Its Debt
Sep 28Here's Why Selvita (WSE:SLV) Has Caught The Eye Of Investors
Jun 02Selvita (WSE:SLV) Seems To Use Debt Quite Sensibly
Jun 09These 4 Measures Indicate That Selvita (WSE:SLV) Is Using Debt Reasonably Well
Feb 23If You Like EPS Growth Then Check Out Selvita (WSE:SLV) Before It's Too Late
Mar 31Here's What Selvita S.A.'s (WSE:SLV) Shareholder Ownership Structure Looks Like
Feb 25Here's Why We Don't Think Selvita's (WSE:SLV) Statutory Earnings Reflect Its Underlying Earnings Potential
Jan 22
Is Now The Time To Put Selvita (WSE:SLV) On Your Watchlist?
Dec 25Did You Miss Selvita's (WSE:SLV) Impressive 113% Share Price Gain?
Dec 02Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | zł54m |
| Jun 30 2024 | n/a | n/a | zł47m |
| Mar 31 2024 | n/a | n/a | zł65m |
| Dec 31 2023 | zł1m | zł658k | zł70m |
| Sep 30 2023 | n/a | n/a | zł20m |
| Jun 30 2023 | n/a | n/a | zł31m |
| Mar 31 2023 | n/a | n/a | zł24m |
| Dec 31 2022 | zł1m | zł480k | zł26m |
| Sep 30 2022 | n/a | n/a | zł20m |
| Jun 30 2022 | n/a | n/a | zł11m |
| Mar 31 2022 | n/a | n/a | zł12m |
| Dec 31 2021 | zł1m | zł1m | zł15m |
| Sep 30 2021 | n/a | n/a | zł12m |
| Jun 30 2021 | n/a | n/a | zł18m |
| Mar 31 2021 | n/a | n/a | zł22m |
| Dec 31 2020 | zł697k | n/a | zł18m |
| Sep 30 2020 | n/a | n/a | zł21m |
| Jun 30 2020 | n/a | n/a | zł15m |
| Mar 31 2020 | n/a | n/a | zł9m |
| Dec 31 2019 | zł186k | zł113k | zł7m |
Compensatie versus markt: De totale vergoeding ($USD 267.06K ) Boguslaw } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Polish markt ($USD 278.47K ).
Compensatie versus inkomsten: De vergoeding van Boguslaw is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Boguslaw Sieczkowski
no data
Tenure
zł1,100,903
Compensatie
Mr. Boguslaw Stanislaw Sieczkowski, M.B.A, is Chief Executive Officer and Chairman of Management Board at SELVITA S.A. Mr. Sieczkowski served as Chief Operating Officer, Executive Vice President and Vice P...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman of Management Board & CEO | no data | zł1.10m | 5.13% PLN 50.4m | |
| Chief Commercial Officer | no data | zł1.09m | 0.33% PLN 3.3m | |
| CFO & Member of the Management Board | 5.3yrs | zł590.72k | 0.023% PLN 229.3k | |
| COO & Member of the Management Board | 2.8yrs | zł644.19k | 0.23% PLN 2.3m | |
| General Counsel & Member of the Management Board | no data | zł672.21k | 0.024% PLN 239.2k | |
| Global Head of Drug Discovery & Member of the Management Board | 2.8yrs | zł1.25m | 0.065% PLN 642.0k |
2.8yrs
Gemiddelde duur
Ervaren management: Het managementteam van SLV wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.8 jaar).